BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li N, Shen J, Qiao X, Gao Y, Su HB, Zhang S. Long Non-Coding RNA Signatures Associated with Ferroptosis Predict Prognosis in Colorectal Cancer. Int J Gen Med 2022;15:33-43. [PMID: 35018112 DOI: 10.2147/IJGM.S331378] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu C, He T, Shao X, Gao L, Cao L. m6A-related lncRNAs are potential biomarkers for the prognosis of COAD patients. Front Oncol 2022;12:920023. [DOI: 10.3389/fonc.2022.920023] [Reference Citation Analysis]
2 Xu M, Mu J, Wang J, Zhou Q, Wang J. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma. Front Oncol 2022;12:961213. [DOI: 10.3389/fonc.2022.961213] [Reference Citation Analysis]
3 Li YJ, Li HY, Zhang Q, Wei SL. The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma. Front Genet 2022;13:942785. [DOI: 10.3389/fgene.2022.942785] [Reference Citation Analysis]
4 Wu J, Song Q, Huang C, Shao Y, Wang Z, Zhang H, Fu Z. N7-methylguanosine-related lncRNAs: Predicting the prognosis and diagnosis of colorectal cancer in the cold and hot tumors. Front Genet 2022;13:952836. [DOI: 10.3389/fgene.2022.952836] [Reference Citation Analysis]
5 Hou J, Lu Z, Cheng X, Dong R, Jiang Y, Wu G, Qu G, Xu Y. Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer. BMC Cancer 2022;22:719. [PMID: 35768833 DOI: 10.1186/s12885-022-09805-9] [Reference Citation Analysis]
6 He R, Man C, Huang J, He L, Wang X, Lang Y, Fan Y. Identification of RNA Methylation-Related lncRNAs Signature for Predicting Hot and Cold Tumors and Prognosis in Colon Cancer. Front Genet 2022;13:870945. [PMID: 35464855 DOI: 10.3389/fgene.2022.870945] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Xue Y, Ning B, Liu H, Jia B. Construction of immune-related lncRNA signature to predict aggressiveness, immune landscape, and drug resistance of colon cancer. BMC Gastroenterol 2022;22:127. [PMID: 35300596 DOI: 10.1186/s12876-022-02200-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]